NexMR AG

NexMR AG is a pioneering biotechnology research company dedicated to accelerating drug discovery through cutting-edge NMR (Nuclear Magnetic Resonance) technology. NexMR AG offers advanced NMR drug design solutions engineered for unparalleled speed and efficiency. By significantly reducing the time and sample material required, NexMR empowers researchers to achieve breakthroughs faster and more cost-effectively.

Located in Schlieren, Zürich 8952, CH, NexMR AG is committed to innovation in pharmaceutical research. The company’s platforms are versatile, operating on both high-field NMR instruments with cryoprobes and automatic sampling robots, as well as low-field NMR benchtop spectrometers. This adaptability ensures accessibility and broad applicability for various research environments. NexMR AG is focused on delivering superior results and driving advancements in the biotechnology sector.

NexMR AG’s expertise lies in fragment-based lead design, hit-to-lead processes, and overall drug discovery. These specialized services enable pharmaceutical companies and research institutions to optimize their drug development pipelines. We invite the manager of NexMR AG to create a customized and exclusive company showcase and product listing on our platform, enhancing visibility and fostering new collaborations.